Nano-X Imaging Ltd. Form 6-K Summary
Business context and reporting period
Nano-X Imaging Ltd. furnished this Form 6-K for December 2022. The filing reports the results of the company’s annual general meeting held on December 28, 2022, at its offices in Neve Ilan, Israel.
Key financial metrics and capital structure
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial operating metrics.
Material changes versus the prior comparable period
- Shareholders re-elected Erez Alroy and Noga Kainan as Class II directors, each to serve until the 2025 annual general meeting and until a successor is elected and qualified.
- Shareholders approved option awards for non-executive directors Erez Alroy, Noga Kainan, and Dan Suesskind. The filing does not specify the number, exercise price, vesting terms, or fair value of the options.
- Shareholders approved the compensation of Ran Poliakine as non-executive Chairman of the Board.
- Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, was re-appointed as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 and until the next annual meeting.
- Dr. Floyd Katske retired from the Board effective as of the meeting.
Guidance, outlook, risks, and unusual items
The filing contains no financial guidance, operating outlook, risk discussion, contingencies, or unusual financial items. It states that the proposals had been described in the company’s November 10, 2022 Form 6-K proxy materials.
Important facts for investors to verify
- Review the November 10, 2022 Form 6-K and attached proxy statement for the detailed terms of the director option awards and Chairman compensation.
- Verify the company’s subsequent annual report for fiscal 2022 financial results and liquidity information.
- Monitor the composition of the Board following Dr. Katske’s retirement and the re-election of the Class II directors.
- Note that the filing’s information is incorporated by reference into the company’s Form S-8 registration statement, File No. 333-248322.